MIM
AMPE

MetLife Investment Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

MetLife Investment Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-103
Closed -$51.4K – 2587
2021
Q3 		$51.4K Sell
103
-161
-61% -$74.6K ﹤0.01% 2530
2021
Q2 		$132K Buy
+264
New +$142K ﹤0.01% 2372

Other funds holding AMPE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

MetLife Investment Management's AMPE Position: Q4 2021 in Review

MetLife Investment Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2021, closing a stake of 103 shares — an estimated $51.4K sold.

MetLife Investment Management first reported a position in AMPE in Q2 2021 and held it in 2 quarters. The position peaked at $132K in Q2 2021. 131 funds tracked by Wall St. Rank hold AMPE as of Q4 2021.

  • MetLife Investment Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2021 after selling out during the quarter.
  • MetLife Investment Management sold 103 Ampio Pharmaceuticals Inc. shares in Q4 2021, an estimated $51.4K.
  • MetLife Investment Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2021 and held it in 2 quarters.
  • MetLife Investment Management's Ampio Pharmaceuticals Inc. position peaked at $132K in Q2 2021.
  • 131 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2021.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.